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The study of isolated primary progenitor cells offers great insight into developmental biology and human disease. In particular, ex vivo culture of isolated primary erythroid progenitor cells replicates the differentiation events that occur during in vivo erythropoiesis. Here we report a high-efficiency method for CRISPR-Cas9 mediated gene disruption in isolated primary erythroid progenitor cells. We use this method to generate the novel result that Lmna is required in terminal erythroid differentiation.
Terminal erythroid differentiation is initiated by binding of Erythropoietin (Epo) to Epo receptors on the surface of CFU-E erythroid progenitors, leading to 3 to 6 terminal divisions, induction of ~600 genes, and repression of thousands of others in a defined temporal order. Concomitantly there are major changes in cytoskeletal and nuclear architecture, including condensation of the nucleus to about one-tenth its original volume and, only in mammals, enucleation. 1, 2, 3 Numerous human diseases cause disordered erythropoiesis and result in significant morbidity and mortality. In many cases the underlying mechanisms of disease are incompletely understood, and more importantly, identification of disease modifier genes and their function in terminal erythropoiesis is incomplete. 4 Ex vivo culture and differentiation of isolated primary mouse erythroid progenitor cells faithfully mimics the cellular events that occur during in vivo erythropoiesis, including proliferation, upregulation of erythroid-specific genes and cell surface markers, accumulation of hemoglobin, and enucleation. 5 RNA interference has been used for the study of gene function in erythropoiesis, but the use of small hairpin RNAs is complicated 3
by difficulty in predicting efficiency of gene knockdown and non-specific effects. 6 Several genetic determinants of erythropoiesis have been assessed using erythroid progenitors isolated from gene knock-out mice, 7, 8 Figure 1A ). Using this vector we transduced primary lineage negative erythroid progenitor cells purified from E14.5 mouse fetal livers, and cultured them in an erythroid progenitor expansion media containing cytokines that promote proliferation but not differentiation. GFP positive cells were isolated by fluorescence activated cell sorting (FACS) between 24 to 72 hours posttransduction depending on the desired degree of cell expansion ( Figure 1B ).
Importantly, our retroviral vector delivering Cas9 and sgRNA was capable of high efficiency transduction such that the majority of the progenitor cell population was successfully transduced ( Figure 1C ). GFP positive cells were then placed in erythroid differentiation medium for 48 hours ( Figure 1B ).
To assay gene disruption efficiency we co-delivered Cas9 with three different sgRNAs (Supplemental Table S1 replicating the phenotype observed in mice genetically deficient in Bcl11a ( Figure 1H ).
We next used this system to identify a novel regulator of terminal erythroid differentiation.
As prior studies of erythropoiesis had not placed significant emphasis on structural proteins, we analyzed expression data for all genes encoding such types of proteins.
Lmna, the gene encoding the alternatively spliced nuclear envelope proteins Lamins A and C, exhibited the greatest increase in expression during terminal erythroid differentiation, with a 4 to 6-fold increase in relative expression quantified by RNA-seq methods. 2 This was in contrast to Lamin B, a protein that complexes with Lamins A and 6
C to support nuclear membrane architecture and control transcriptional regulation, but is downregulated during terminal erythroid differentiation. 3, 11, 12 Interestingly, Lamin A protein exhibited a marked initial increase during terminal differentiation followed by a marked decrease (Figures 2A, 2B) , whereas Lamin C protein levels were not as dynamic (Supplemental Figure S2) .
We designed an sgRNA targeting the start codon of Lmna (Supplemental Figure S1 ). There was no difference in upregulation of cell surface markers CD71 and Ter119 (Supplemental Figure S3) , which are relatively earlier events during terminal erythroid differentiation. 1 These results are the first demonstration that expression of Lmna is dynamically regulated during erythropoiesis and that it plays a significant role in terminal red cell differentiation. Although an anemia phenotype has not been reported for Lmna -/-mice, they do have decreased growth by 3 weeks and die by 8 weeks of life; 13 it will be interesting to determine whether young Lmna -/-mice do exhibit an anemia phenotype under both normal and stress erythropoiesis conditions. 14 Further biochemical analyses 7 will be instrumental in determining the underlying mechanism by which Lmna regulates terminal erythroid differentiation.
The method we developed for using CRISPR-Cas9 to study genetic loss of function in isolated primary erythroid progenitor cells provides a broadly generalizable, rapid, and facile assessment of gene function in red blood cell development, with a total duration of 3 to 5 days from progenitor cell isolation to phenotypic assessment. Although off-target effects of the CRISPR-Cas9 system are of concern, high-throughput sequencing or array CGH methods can be used to identify off-target cleavage events, and rescue experiments using cDNAs of targeted genes where codons have been substituted to ablate sgRNA binding without changing the amino acid sequence can confirm whether the observed phenotype is due to on-target or off-target gene disruption. Additionally, the use of novel Cas9 variants with high specificity will mitigate many of these concerns. 15 Our system has significant strengths in the high transduction rate of our viral vector co-expressing Cas9 and an sgRNA, and the high efficiency with which gene disruption can be achieved, both of which are key considerations when studying rare and difficult-to-isolate cell populations such as hematopoietic progenitors. Indeed, the ability to achieve high-efficiency gene disruption using this system allows the possibility of robust large-scale genetic loss-of-function screening in erythropoiesis. 
Supplemental Methods

Plasmids
The SpCas9 cDNA was PCR amplified from plasmid pX330 16 (a kind gift of Dr. Feng Zhang, Broad Institute) using Phusion polymerase (New England Biolabs) and cloned into the pXZ201 MSCV retroviral vector plasmid 17 using EcoRI (New England Biolabs) and XhoI (New England Biolabs) restriction sites. The 2A-GFP cDNA was PCR amplified from pXZ201 using Phusion polymerase and an extended primer encoding the 2A cDNA and cloned in 3' to the SpCas9 cDNA using a SalI (New England Biolabs) restriction site. The self-cleaving 2A peptide sequence was constructed as previously described. 18 The U6 promoter, BbsI restriction site, sgRNA construct was PCR amplified from plasmid pX330 using Phusion polymerase and cloned in reverse orientation 3' to the GFP cDNA using a NotI (New England Biolabs) restriction site. Specific guide RNAs were synthesized as complimentary oligos (Integrated DNA Technologies), phosphorylated with T4 polynucleotide kinase (New England Biolabs), annealed, and cloned into the BbsI (New England Biolabs) site.
Retrovirus production
The 293T cells used for transfection were split and plated at 6 million cells per 10 cm plate on day -1 in antibiotic -free Dulbecco's Modified Eagle Medium (DMEM) with added 15% Fetal Bovine Serum (FBS) and 2 mM L-Glutamine (Invitrogen). On day 0, 10 ug plasmids were transfected into 293T cells together with 5 µg packaging vector (pCL-Eco, IMGENEX) using Fugene 6 (Promega). Six hours later, the culture medium was replaced with DMEM with added 15% FBS, 2 mM L-Glutamine and 1× Pen Strep (Invitrogen). On day 1, fresh virus -containing supernatant was collected, filtered through 0.45 µm filter (Millipore), and used immediately to infect the murine lineage negative fetal liver cells.
Isolation of erythroid progenitors from murine E14.5 fetal liver cells
Day 14.5 pregnant C57BL/6J mice were anesthetized by carbon dioxide. The embryos were isolated and the entire fetal livers were carefully collected in Phosphate Buffered Saline (PBS) with 2% Fetal Bovine Serum (FBS) and 100 µM EDTA. After suspension by pipette tips and filtration through a 70 µm filter (BD), the fetal liver cells were incubated with Ammonium Chloride Solution (Stemcell) for lysis of red blood cells. Ten minutes later, the remaining fetal liver cells were centrifuged at 300x(g) for 5 minutes, and resuspended in PBS. Following the manufacturer's protocol, lineage negative cells were obtained after depletion of lineage positive cells magnetically using BD Biotin Mouse Lineage Panel (559971) and BD Streptavidin Particles Plus -DM (557812). The detail protocol was described previously. 5 One fetal liver resulted in the isolation of 500,000 lineage-negative progenitor cells.
Viral infection and culture of erythroid progenitors
After isolation, lineage negative fetal liver cells were plated in 24-well plates with 100,000 cells per well, covered by 1 ml virus containing supernatant, and centrifuged at 400x(g) for 90 min at 37°C. After spin-infection, we replaced the virus supernatant with erythroid maintenance medium (StemSpan-SFEM (StemCell Technologies) with added recombinant mouse stem cell factor (100 ng/ml SCF, R&D), recombinant mouse IGF-1 (40 ng/ml, R&D), dexamethasone (100 nM, Sigma) and erythropoietin (2 u/ml, Amgen)). The cells were cultured overnight or for up to three days for recovery and expression of transgenes. Then infected cells were pooled and sorted for green fluorescence by FACS sorting at flow rate 2. The GFP+ cells were cultured in Epo-only erythroid differentiation medium (Iscove modified Dulbecco's medium (IMDM) containing 15% FBS (Stemcell), 1% detoxified bovine serum albumin (BSA) (Stemcell), 500 µg/mL holo-transferrin (Sigma-Aldrich), 0.5 U/mL Epo (Amgen), 10 µg/mL recombinant human insulin (Sigma-Aldrich), 2 mM L-glutamine (Invitrogen) and 1× Pen Strep (Invitrogen)).
Flow cytometry (FACS) sorting and analysis
The cells were pooled, washed once in PBS and resuspended at density of 5-10 million/ml in PBS with 1 µg/ml PI for FACS sorting or analysis. Ter119 staining was performed using APC Rat Anti-Mouse TER-119 (BD Biosciences) and CD71 staining was performed using PE Rat Anti-Mouse CD71 (BD Biosciences) as per manufacturer's instructions. FACS was performed using an ARIA-II sorter Supplemental Figure S3 
